{"transactions":[{"id":736085,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:15.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069245","document":"marketforms-73182.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390026069245/marketforms-73182.xml","form_type":"4"}},{"id":1111489,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:11.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054283","document":"marketforms-69813.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390025054283/marketforms-69813.xml","form_type":"4"}},{"id":1484788,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:00:12.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-051376","document":"marketforms-66259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390024051376/marketforms-66259.xml","form_type":"4"}},{"id":1692079,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:21:24.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":108333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2024."}],"balance_after":108333,"derivative":{"exercise_price":0.6,"expiration_date":"2034-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":108333},"source":{"system":"sec-edgar","filing":"0001178913-24-000055","document":"zk2430736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000117891324000055/zk2430736.xml","form_type":"4"}},{"id":1862144,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:10:51.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.85,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-23-047472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390023047472/ownership.xml","form_type":"4"}},{"id":2067154,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-04T21:23:05.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":89041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 2, 2023."}],"balance_after":89041,"derivative":{"exercise_price":0.73,"expiration_date":"2033-01-02","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":89041},"source":{"system":"sec-edgar","filing":"0001178913-23-000055","document":"zk2328964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000117891323000055/zk2328964.xml","form_type":"4"}},{"id":2237663,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T20:10:18.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":3.5,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-031991","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000121390022031991/ownership.xml","form_type":"4"}},{"id":2437650,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:08:34.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":107557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest ratably on a quarterly basis over a three-year period that commenced on January 1, 2022."}],"balance_after":107557,"derivative":{"exercise_price":2.815,"expiration_date":"2032-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":107557},"source":{"system":"sec-edgar","filing":"0001178913-22-000089","document":"zk2227044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000117891322000089/zk2227044.xml","form_type":"4"}},{"id":2437649,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-11T21:08:34.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":35852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2022."}],"balance_after":35852,"derivative":{"exercise_price":2.815,"expiration_date":"2032-01-01","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":35852},"source":{"system":"sec-edgar","filing":"0001178913-22-000089","document":"zk2227044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000117891322000089/zk2227044.xml","form_type":"4"}},{"id":2673878,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T00:05:35.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":10.51,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-039683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000120919121039683/doc4.xml","form_type":"4"}},{"id":3113315,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:38:19.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":9000,"derivative":{"exercise_price":35,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-035848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000120919120035848/doc4.xml","form_type":"4"}},{"id":3113314,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T17:37:09.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":12399,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Merger in exchange for a stock option to acquire 65,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option Shares shall vest in forty eight (48) approximately equal increments of two hundred fifty eight (258) whole Option Shares beginning on the first day of the first calendar month following December 24, 2018, and then on the first day of each of the next forty seven (47) months thereafter (each a \"Vesting Date\"), if Reporting Person has remained continuously engaged by the Issuer or any Affiliate through such Vesting Date; provided that, on the last such Vesting Date (being December 1, 2022), all of the Option Shares which had not vested by then will vest and become exercisable."}],"balance_after":12399,"derivative":{"exercise_price":9.18,"expiration_date":"2028-12-23","underlying":"Common Stock","underlying_shares":12399},"source":{"system":"sec-edgar","filing":"0001209191-20-035847","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000120919120035847/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-13"}},{"id":3312565,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:18:24.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":10491,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 55,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/48th of the shares subject to the option shall vest monthly following April 29, 2019, for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":10491,"derivative":{"exercise_price":9.18,"expiration_date":"2029-04-28","underlying":"Common Stock","underlying_shares":10491},"source":{"system":"sec-edgar","filing":"0001209191-20-003239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000120919120003239/doc4.xml","form_type":"4"}},{"id":3312564,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T00:18:24.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":12399,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 65,000 shares of ArTara Sub common stock for $1.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option shall vest monthly thereafter for so long as the Reporting Person provides continuous service to the Issuer."}],"balance_after":12399,"derivative":{"exercise_price":9.18,"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":12399},"source":{"system":"sec-edgar","filing":"0001209191-20-003239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000120919120003239/doc4.xml","form_type":"4"}},{"id":3312563,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37660,"kind":"person","name":"GARCEAU ROGER","position":1,"cik":"0001451767","reported_name":"GARCEAU ROGER","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-14T00:18:24.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock unit awards (\"RSUs\"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 3/24th of the shares were vested upon grant and 1/24th of the shares vest monthly thereafter, beginning on February 10, 2020. Settlement for the RSUs is deferred until the earliest to occur of (i) the Reporting Person's termination of service, (ii) death, (iii) disability and (iv) a change in control of the Issuer. In the event of a change in control of the Issuer, the RSUs will vest in full."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001209191-20-003239","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1451767/000120919120003239/doc4.xml","form_type":"4"}}]}